Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.52 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.51 |
| ▸ | ALB | P02768 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2712703 | 0.84 | PPARA (0.55) | PPARAPLA2G4BALBGAAFFAR1 | |
| SCHEMBL21073528 | 0.82 | PPARA (0.71) | PPARAPLA2G4BALBGAAL3MBTL1 | |
| SCHEMBL29141429 | 0.82 | PPARA (0.71) | PPARAPLA2G4BALBGAAL3MBTL1 | |
| SCHEMBL31448424 | 0.82 | PPARA (0.71) | PPARAPLA2G4BALBGAAL3MBTL1 | |
| SCHEMBL31448470 | 0.80 | PPARA (0.73) | PPARAPLA2G4BALBGAAL3MBTL1 | |
| SCHEMBL28633426 | 0.80 | PPARA (0.56) | PPARAPLA2G4BALBL3MBTL1FFAR1 | |
| SCHEMBL810034 | 0.80 | ALDH1A1 (0.57) | GAAL3MBTL1FFAR1PPARD | |
| SCHEMBL810044 | 0.79 | ALDH1A1 (0.43) | PLA2G4BGAAL3MBTL1PPARD | |
| SCHEMBL7568345 | 0.78 | GAA (0.80) | PPARAPLA2G4BALBGAAL3MBTL1 | |
| SCHEMBL13348918 | 0.78 | GAA (0.80) | PPARAPLA2G4BALBGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902319-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-03-08 | — | — | US | disclosed |
| US-20100113592-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2010-05-06 | — | — | US | disclosed |
| US-7671168-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-20070141113-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113592-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | DDT, ACMSD, HPD | PPARA 1948/4885PLA2G4B 4319/4885ALB 1726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.